| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research
1 company
Murphy Andrew J is an EVP Research at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 64 sells.
Estimated insider holdings value: $29.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 6,628 | $542.73 | $3,597,187.72 | -0.7% | |
| Jul 14, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 11,929 | $626.98 | $7,479,298.86 | -0.9% | |
| Jul 14, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 2,380 | $633.48 | $1,507,677.39 | -0.6% | |
| Jan 27, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sell | 8,000 | $340.91 | $2,727,279.25 | -1.8% |